Skip to content

Apic Bio vs Coave Therapeutics

Apic Bio logo

Apic Bio

Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Antitrypsin Deficiency, genetic ALS, and other CNS conditions

est. 2017

VS
Coave Therapeutics logo

Coave Therapeutics

Coave therapeutics new brand for Horama

36 employees · est. 2014 · Paris, France

Coave Therapeutics is the older company (2017 vs 2014).

Side-by-Side Comparison

Apic Bio Coave Therapeutics
Founded
2017 2014 older
Headquarters
Not tracked yet Paris, France
Employees
Not tracked yet 36
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Life Sciences
Funding Stage
Series A Grant
Total Funding
$53.32M $79.10M
Funding Rounds
3 7
Taxonomy
Gene TherapyRare DiseasesNeurological DisordersLiver DiseasesAlpha-1 Antitrypsin DeficiencyALS +4 Gene TherapyOphthalmic DisordersCNS DisordersRare DiseasesClinical Stage CompanyAAV-Ligand Conjugates Technology +4
Website
apic-bio.com coavetx.com
Apic Bio logo

About Apic Bio

Apic Bio is a biotechnology startup founded in 2017 with a focus on pioneering gene therapies for rare neurological and liver diseases. The company's mission is to address underserved medical conditions, including Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS),...

Coave Therapeutics logo

About Coave Therapeutics

Coave Therapeutics, a clinical stage biotechnology company, is dedicated to developing life-changing gene therapies for rare ocular and central nervous system (CNS) diseases. The company leverages its innovative AAV-Ligand Conjugates platform (ALIGATER) to enable targeted delivery and enhanced gene...

Also comparing in this category

Comparing more than these two?

Get Apic Bio, Coave Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Apic Bio compare?

A PDF of Apic Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Apic Bio was founded in 2017. Apic Bio is a biotechnology startup founded in 2017 with a focus on pioneering gene therapies for rare neurological and liver diseases. The company's mission is to address underserved medical conditio. Coave Therapeutics was founded in 2014, based in Paris, France, with 36 employees. Coave Therapeutics, a clinical stage biotechnology company, is dedicated to developing life-changing gene therapies for rare ocular and central nervous system (CNS) diseases. The company leverages its.
Apic Bio has raised $53.32M and Coave Therapeutics $79.10M. Latest stage: Apic Bio Series A, Coave Therapeutics Grant.
Both work in Biotechnology and Life Sciences and list gene therapy and rare diseases among their focus areas.

Compare Apic Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Apic Bio on 12 Sep 2024, and Coave Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout